| 價(jià)格 | 詢價(jià) | ¥9255 |
| 包裝 | 5mg | 2mg |
| 最小起訂量 | 2mg |
| 發(fā)貨地 | 上海 |
| 更新日期 | 2026-06-29 |
| 中文名稱:化合物 S130 | 英文名稱:S130 |
| CAS:1160852-22-1 | 品牌: TargetMol |
| 產(chǎn)地: 美國(guó) | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 產(chǎn)品類別: 抑制劑 | |
| 貨號(hào): T001|T12819 |
| 名稱 | S130 |
| 描述 | S130 is a high affinity, selectiveATG4B (a major cysteine protease) inhibitor (IC50 of 3.24 μM).It suppresses autophagy flux. |
| 體外活性 | S130 suppresses autophagy and activates apoptosis by inhibiting ATG4B, leads to enhanced cytotoxicity. S130 (0-25 μM; 48 hours) induces cell death through inhibiting the activity of ATG4B at a dose higher than 6.3 μM. And such cytotoxicity might not cause cell death through necroptosis. Nutrient deprivation enhances S130-induced cytotoxicity. S130 (0-10μM; 24 hours) suppresses approximately 79% of the cleavage of full-length LC3-GST at the 10 μM, while no substrates were processed in ATG4B KO cells. S130 displays obvious inhibitory effects on ATG4B. |
| 體內(nèi)活性 | Tumor growth suppressed by S130 (20 mg/kg; i.p.; daily; 3 weeks), S130 shows an efficient in vivo antitumor effect with a sound safety on vital organs. |
| 存儲(chǔ)條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度 | 10% DMSO+40% PEG300+5% Tween-80+45% Saline : 3.3 mg/mL (8.52 mM), Sonication is recommended. DMSO : 125 mg/mL (322.61 mM), Sonication is recommended. |
| 關(guān)鍵字 | S-130 | S130 | S 130 | CysteineProtease | Cysteine Protease | ATG4B |
| 相關(guān)產(chǎn)品 | Urea | Formamide | Guanidine hydrochloride | Naringin | Aceglutamide | Alginic acid | Dextran sulfate sodium salt (MW 5000) | Hemin | Hydroxychloroquine | Stavudine | Tamoxifen | Paeonol |
| 成立日期 | 2013-04-18 (14年) | 注冊(cè)資本 | 566.265100萬人民幣 |
| 員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
| 主營(yíng)行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營(yíng)模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
| 產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
|---|---|---|---|---|
| 詢價(jià) |
河北冀肽生物科技有限公司
|
2026-07-29 | ||
| 詢價(jià) |
VIP8年
|
廣州市桐暉藥業(yè)有限公司
|
2026-06-02 | |
| 詢價(jià) |
VIP1年
|
河南伊諾凱新材料有限公司
|
2026-06-08 |